Skip to main content

Tim Willson

September 24, 2018

Assay Development, Chemical Libraries, Cheminformatics, Computational Drug Design, Machine Learning, Allosteric Modulators, Chemical Biology, Chemical Probes, Drug Discovery, Fragment Based Drug Design, Protein Kinase Inhibitors, Protein Kinases, Rare Diseases, Structure Activity Relationship, Synthetic Chemistry

Eugene Muratov

September 24, 2018

Artificial Intelligence, Cheminformatics, In Silico Modeling, Mathematical Modelling, QSAR, Cheminformatics, Computational Modeling, Data Science, Diabetes, Drug Delivery, Drug Discovery, Drug Safety, Health Outcomes, Machine Learning

Dmitri Kireev

September 24, 2018

Artificial Intelligence, Cheminformatics, Computational Drug Design, In Silico Modeling, Machine Learning, Mathematical Modelling Biophysics, Cancer, Chemical Biology, Chemical Probes, Chromatin, Computational Modeling, Drug Discovery, Machine Learning, Protein Kinase Inhibitors, Structure-based Drug Dosing

Alexander Golbraikh

September 24, 2018

Artificial Intelligence, Cheminformatics, Computational Drug Design, In Silico Modeling, Mathematical Modelling Computational Modeling, Data Science, Dementia, Drug Development, Drug Discovery, Health Policy, Heart Disease, Heart Failure, Machine Learning, Toxicology

David Drewry

September 24, 2018

ADME profiling, Assay Development, Chemical Libraries, Cheminformatics, Physicochemical Characterization Chemical Biology, Chemical Probes, Drug Discovery, Fragment Based Drug Design, Oncology, Protein Kinase Inhibitors, Protein Kinases, Rare Diseases, Structure Activity Relationship, Synthetic Chemistry

Alex Tropsha

September 24, 2018

ADME profiling, Artificial Intelligence, Cheminformatics, Computational Drug Design, In Silico Modeling, Machine Learning, Bioinformatics, Cheminformatics, Computational Modeling, Data Science, Drug Delivery, Drug Discovery, Drug Safety, Educational Research, Fragment Based Drug Design, G Protein-coupled Receptors, Machine Learning, Toxicology